Cisen Pharmaceutical Co., Ltd. (603367.SS)
CNY 14.05
(0.0%)
CNY 14.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.01 Billion CNY | 5.0% |
| 2022 | 1.91 Billion CNY | 5.93% |
| 2021 | 1.81 Billion CNY | 7.76% |
| 2020 | 1.68 Billion CNY | -7.87% |
| 2019 | 1.82 Billion CNY | 13.0% |
| 2018 | 1.61 Billion CNY | 50.3% |
| 2017 | 1.07 Billion CNY | 41.94% |
| 2016 | 756.91 Million CNY | 24.67% |
| 2015 | 607.13 Million CNY | 3.21% |
| 2014 | 588.26 Million CNY | 3.36% |
| 2013 | 569.12 Million CNY | 16.58% |
| 2012 | 488.16 Million CNY | 47.4% |
| 2011 | 331.18 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 370.52 Million CNY | -27.48% |
| 2024 Q1 | 510.91 Million CNY | -12.52% |
| 2024 Q3 | 406.42 Million CNY | 1.39% |
| 2023 Q2 | 406.48 Million CNY | -26.0% |
| 2023 FY | 2.01 Billion CNY | 5.0% |
| 2023 Q1 | 549.33 Million CNY | -3.14% |
| 2023 Q3 | 475.06 Million CNY | 16.87% |
| 2023 Q4 | 584 Million CNY | 22.93% |
| 2022 Q1 | 372.86 Million CNY | -23.19% |
| 2022 FY | 1.91 Billion CNY | 5.93% |
| 2022 Q4 | 567.16 Million CNY | 9.85% |
| 2022 Q3 | 516.31 Million CNY | 11.62% |
| 2022 Q2 | 462.58 Million CNY | 24.06% |
| 2021 Q1 | 414.27 Million CNY | -1.45% |
| 2021 FY | 1.81 Billion CNY | 7.76% |
| 2021 Q4 | 485.4 Million CNY | 6.48% |
| 2021 Q3 | 455.87 Million CNY | -0.02% |
| 2021 Q2 | 455.97 Million CNY | 10.07% |
| 2020 Q3 | 434.83 Million CNY | -6.93% |
| 2020 FY | 1.68 Billion CNY | -7.87% |
| 2020 Q4 | 420.38 Million CNY | -3.32% |
| 2020 Q2 | 467.22 Million CNY | 31.65% |
| 2020 Q1 | 354.89 Million CNY | -38.76% |
| 2019 Q1 | 439.48 Million CNY | 4.84% |
| 2019 Q2 | 393.84 Million CNY | -10.38% |
| 2019 Q3 | 409.97 Million CNY | 4.09% |
| 2019 FY | 1.82 Billion CNY | 13.0% |
| 2019 Q4 | 579.53 Million CNY | 41.36% |
| 2018 Q3 | 405.07 Million CNY | -0.16% |
| 2018 Q2 | 405.73 Million CNY | 5.47% |
| 2018 Q1 | 384.7 Million CNY | 7.62% |
| 2018 FY | 1.61 Billion CNY | 50.3% |
| 2018 Q4 | 419.2 Million CNY | 3.49% |
| 2017 Q4 | 357.47 Million CNY | 24.11% |
| 2017 Q3 | 288.02 Million CNY | 20.8% |
| 2017 Q2 | 238.42 Million CNY | 26.5% |
| 2017 Q1 | 188.48 Million CNY | -25.48% |
| 2017 FY | 1.07 Billion CNY | 41.94% |
| 2016 Q3 | 151.95 Million CNY | 0.0% |
| 2016 Q4 | 252.91 Million CNY | 66.44% |
| 2016 FY | 756.91 Million CNY | 24.67% |
| 2015 Q1 | 135.54 Million CNY | 0.0% |
| 2015 Q2 | 135.54 Million CNY | 0.0% |
| 2015 FY | 607.13 Million CNY | 3.21% |
| 2014 FY | 588.26 Million CNY | 3.36% |
| 2013 FY | 569.12 Million CNY | 16.58% |
| 2012 FY | 488.16 Million CNY | 47.4% |
| 2011 FY | 331.18 Million CNY | 0.0% |